Catalyst Biosciences (NASDAQ: CBIO)
Catalyst Biosciences Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Catalyst Biosciences Company Info
Catalyst Biosciences, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on March 7, 1997 and is headquartered in South San Francisco, CA.
News & Analysis
2 Biotech Stocks That Tanked This Week: Can They Recover?
A bad week for these two biotechs could be a good week for bargain shoppers.
Why Biogen, Baytex Energy, and Catalyst Biosciences Slumped Today
Find out why good news elsewhere hurt one of these stocks.
2 Biotech Stocks Making Waves
The notable moves and news of the day.
2 Biotechs' Very Bad Day
These stocks sank like rocks.
Oops, Our Data Weren't That Good
Targacept revises its data for TC-6987 downward.
3 Stocks to Get on Your Watchlist
Are these three stocks set up for a large move?
Depressing Clinical Trial News
This adjunct depression treatment is done.
5 of Last Week's Biggest Losers
These five stocks only made shorts some serious money last week.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.